Polynovo Ltd (ASX:PNV) is an Australian medical device company that designs, develops, and manufactures dermal regeneration solutions using its patented NovoSorb biodegradable polymer technology.
Shares in S&P/ASX 200 (ASX: XJO) company PoloNovo Ltd (ASX: PNV) have rallied in recent months following a string of positive announcements.
The PolyNovo Ltd (ASX: PNV) share price shot up 8.73% yesterday after announcing Taiwan FDA approval. Is it time to buy PolyNovo shares?
PolyNovo Ltd (ASX:PNV) is an exciting name in the health-tech space. It’s been a volatile ride so far, here are my thoughts on this up and coming ASX growth share.
PolyNovo (ASX:PNV) shares are on watch this morning after releasing an FY20 trading update.
The Polynovo Ltd (ASX: PNV) share price leapt 10% higher today after announcing its first product orders for the German, Austrian and Swiss markets.
Shares in Polynovo Ltd (ASX: PNV) have rocketed out of a trading halt this morning by more than 12%. Here’s what you need to know.
